Association between timing of zoledronic acid infusion and hip fracture healing

Osteoporosis International

Volumn 22, Issue 8, 2011, Pages 2329-2336

  Colon Emeric C ^a   Nordsletten, L ^b   Olson, S ^a   Major, N ^c   Boonen, S ^d   Haentjens, P ^e   Mesenbrink, P ^f   Magaziner, J ^g   Adachi, J ^h   Lyles, K W ^a   Hyldstrup, L ⁱ   Bucci Rechtweg, C ^f   Recknor, C ^j  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^f NOVARTIS PHARMA AG   (Switzerland)

^g UNIVERSITY OF MARYLAND   (United States)

^h MCMASTER UNIVERSITY   (Canada)

ⁱ HVIDOVRE HOSPITAL   (Denmark)

^j United Osteoporosis Centers   (United States)

more..

Author keywords

Bisphosphonates; Fracture healing; Hip fracture; Timing of infusion; Zoledronic acid

Indexed keywords

CALCITONIN; CALCIUM; COLECALCIFEROL; ERGOCALCIFEROL; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; RALOXIFENE; VITAMIN D; ZOLEDRONIC ACID;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOLLOW UP; FRACTURE HEALING; FRACTURE NONUNION; HIP FRACTURE; HIP RADIOGRAPHY; HORMONE SUBSTITUTION; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SYMPTOM; TIME; VITAMIN SUPPLEMENTATION;

AGED; AGED, 80 AND OVER; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FRACTURE HEALING; FRACTURES, UNUNITED; HIP FRACTURES; HUMANS; IMIDAZOLES; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; OSTEOPOROTIC FRACTURES; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; RISK FACTORS;

EID: 79960250936     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-010-1473-1     Document Type: Article

References (31)

1. J Magaziner E Lydick W Hawkes KM Fox SI Zimmerman RS Epstein JR Hebel 1997 Excess mortality attributable to hip fracture in white women aged 70 years and older Am J Public Health 87 1630 1636 9357344 10.2105/AJPH.87.10.1630 1:STN:280:DyaK1c%2FitVaitg%3D%3D (Pubitemid 27465238)
2. LJ Melton III 2003 Adverse outcomes of osteoporotic fractures in the general population J Bone Miner Res 18 1139 1141 12817771 10.1359/jbmr.2003.18. 6.1139 (Pubitemid 37294956)
3. C Colón-Emeric M Kuchibhatla C Pieper W Hawkes L Fredman J Magaziner S Zimmerman KW Lyles 2003 The contribution of hip fracture to risk of subsequent fractures: data from two longitudinal studies Osteoporos Int 14 879 883 14530910 10.1007/s00198-003-1460-x (Pubitemid 38009526)
4. KW Lyles CS Colón-Emeric JS Magaziner JD Adachi CF Pieper C Mautalen L Hyldstrup C Recknor L Nordsletten KA Moore C Lavecchia J Zhang P Mesenbrink PK Hodgson K Abrams JJ Orloff Z Horowitz EF Eriksen S Boonen 2007 Zoledronic acid and clinical fractures and mortality after hip fracture N Engl J Med 357 1799 1809 17878149 10.1056/NEJMoa074941 1:CAS:528:DC%2BD2sXht1Kit7nN (Pubitemid 350044800)
5. H Fleisch 2001 Can bisphosphonates be given to patients with fractures? J Bone Miner Res 16 437 440 11277260 10.1359/jbmr.2001.16.3.437 1:CAS:528:DC%2BD3MXhvFKksbk%3D (Pubitemid 32173357)
6. CV Odvina JE Zerwekh DS Rao N Maalouf FA Gottschalk CY Pak 2005 Severely suppressed bone turnover: a potential complication of alendronate therapy J Clin Endocrinol Metab 90 1294 1301 15598694 10.1210/jc.2004-0952 1:CAS:528:DC%2BD2MXisVOhsr0%3D (Pubitemid 40463979)
7. Y Cao S Mori T Mashiba MS Westmore L Ma M Sato T Akiyama L Shi S Komatsubara K Miyamoto H Norimatsu 2002 Raloxifene, estrogen, and alendronate affect the processes of fracture repair differently in ovariectomized rats J Bone Miner Res 17 2237 2246 12469918 10.1359/jbmr.2002.17.12.2237 1:CAS:528:DC%2BD38XpsV2lsb4%3D (Pubitemid 35416758)
8. AE Goodship PC Walker D McNally T Chambers JR Green 1994 Use of a bisphosphonate (pamidronate) to modulate fracture repair in ovine bone Ann Oncol 5 Suppl 7 S53 S55 7873463
9. D Marsh 1998 Concepts of fracture union, delayed union, and nonunion Clin Orthop Relat Res 355 S22 S30 9917623 10.1097/00003086-199810001-00004
10. AA Sama SN Khan ER Myers RC Huang FP Cammisa Jr. HS Sandhu JM Lane 2004 High-dose alendronate uncouples osteoclast and osteoblast function: a study in a rat spine pseudarthrosis model Clin Orthop Relat Res 425 135 142 15292798 10.1097/00003086-200408000-00018 (Pubitemid 39062760)
11. N Amanat M McDonald C Godfrey L Bilston D Little 2007 Optimal timing of a single dose of zoledronic acid to increase strength in rat fracture repair J Bone Miner Res 22 867 876 17371160 10.1359/jbmr.070318 1:CAS:528: DC%2BD2sXpt12jtr0%3D (Pubitemid 351339747)
12. J Li S Mori Y Kaji J Kawanishi T Akiyama H Norimatsu 2000 Concentration of bisphosphonate (incadronate) in callus area and its effects on fracture healing in rats J Bone Miner Res 15 2042 2051 11028459 10.1359/jbmr.2000.15.10. 2042 1:STN:280:DC%2BD3cvnslSruw%3D%3D
13. F Frihagen L Nordsletten JE Madsen 2007 Hemiarthroplasty or internal fixation for intracapsular displaced femoral neck fractures: randomised controlled trial BMJ 335 1251 1254 18056740 10.1136/bmj.39399.456551.25
14. EC Rodriguez-Merchan F Forriol 2004 Nonunion: general principles and experimental data Clin Orthop Relat Res 419 4 12 15021125 10.1097/00003086- 200402000-00003 (Pubitemid 38269664)
15. EF Eriksen KW Lyles CS Colón-Emeric CF Pieper JS Magaziner JD Adachi L Hyldstrup C Recknor L Nordsletten C Lavecchia H Hu S Boonen P Mesenbrink 2009 Antifracture efficacy and reduction of mortality in relation to timing of first dose of zoledronic acid after hip fracture J Bone Miner Res 24 1308 1313 19257818 10.1359/jbmr.090209 1:CAS:528:DC%2BD1MXosFCkt7g%3D
16. JR Lynch LA Taitsman DP Barei SE Nork 2008 Femoral nonunion: risk factors and treatment options J Am Acad Orthop Surg 16 88 97 18252839
17. RW Boyce CL Paddock JR Gleason WK Sletsema EF Eriksen 1995 The effects of risedronate on canine cancellous bone remodeling: three-dimensional kinetic reconstruction of the remodeling site J Bone Miner Res 10 211 221 7754801 10.1002/jbmr.5650100207 1:CAS:528:DyaK2MXmslSktL8%3D
18. C Li S Mori J Li Y Kaji T Akiyama J Kawanishi H Norimatsu 2001 Long-term effect of incadronate disodium (YM-175) on fracture healing of femoral shaft in growing rats J Bone Miner Res 16 429 436 11277259 10.1359/jbmr.2001.16.3.429 1:CAS:528:DC%2BD3MXhvFKksbg%3D (Pubitemid 32173356)
19. J Li S Mori Y Kaji T Mashiba J Kawanishi H Norimatsu 1999 Effect of bisphosphonate (incadronate) on fracture healing of long bones in rats J Bone Miner Res 14 969 979 10352106 10.1359/jbmr.1999.14.6.969 1:CAS:528: DyaK1MXjvFKqur0%3D (Pubitemid 29262892)
20. N Amanat R Brown LE Bilston DG Little 2005 A single systemic dose of pamidronate improves bone mineral content and accelerates restoration of strength in a rat model of fracture repair J Orthop Res 23 1029 1034 16140188 10.1016/j.orthres.2005.03.004 1:CAS:528:DC%2BD2MXpslygsLo%3D (Pubitemid 41245425)
21. A Koivukangas J Tuukkanen K Kippo T Jamsa R Hannuniemi I Pasanen K Vaananen P Jalovaara 2003 Long-term administration of clodronate does not prevent fracture healing in rats Clin Orthop Relat Res 408 268 278 12616070 10.1097/00003086-200303000-00036 (Pubitemid 36307518)
22. CP Peter WO Cook DM Nunamaker MT Provost JG Seedor GA Rodan 1996 Effect of alendronate on fracture healing and bone remodeling in dogs J Orthop Res 14 74 79 8618170 10.1002/jor.1100140113 1:CAS:528:DyaK28Xitl2jtrs%3D (Pubitemid 26091605)
23. P Adolphson H Abbaszadegan H Boden M Salemyr T Henriques 2000 Clodronate increases mineralization of callus after Colles' fracture: a randomized, double-blind, placebo-controlled, prospective trial in 32 patients Acta Orthop Scand 71 195 200 10852328 10.1080/000164700317413193 1:STN:280: DC%2BD3czgvFWlug%3D%3D (Pubitemid 30611747)
24. CF Munns F Rauch L Zeitlin F Fassier FH Glorieux 2004 Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate J Bone Miner Res 19 1779 1786 15476577 10.1359/JBMR.040814 1:CAS:528:DC%2BD2cXhtVSltLnJ (Pubitemid 41103428)
25. DH Solomon MC Hochberg H Mogun S Schneeweiss 2009 The relation between bisphosphonate use and non-union of fractures of the humerus in older adults Osteoporos Int 20 895 901 18843515 10.1007/s00198-008-0759-z 1:CAS:528:DC%2BD1MXls12ktrc%3D
26. SK Goh KY Yang JS Koh MK Wong SY Chua DT Chua TS Howe 2007 Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution J Bone Joint Surg Br 89 349 353 17356148 10.1302/0301-620X.89B3.18146 (Pubitemid 46563912)
27. EB Kwek SK Goh JS Koh MA Png TS Howe 2008 An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy? Injury 39 224 231 18222447 10.1016/j.injury.2007.08.036
28. BA Lenart DG Lorich JM Lane 2008 Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate N Engl J Med 358 1304 1306 18354114 10.1056/NEJMc0707493 1:CAS:528:DC%2BD1cXjvVarsb8%3D (Pubitemid 351439247)
29. M Bhandari GH Guyatt MF Swiontkowski P Tornetta III S Sprague EH Schemitsch 2002 A lack of consensus in the assessment of fracture healing among orthopaedic surgeons J Orthop Trauma 16 562 566 12352564 10.1097/00005131- 200209000-00004 (Pubitemid 35153703)
30. TA Einhorn 1998 Breakout session. 1: definitions of fracture repair Clin Orthop Relat Res 355 S353 9917654 10.1097/00003086-199810001-00035
31. R Hammer S Hammerby B Lindholm 1985 Accuracy of radiologic assessment of tibial shaft fracture union in humans Clin Orthop 199 233 238 4042484 (Pubitemid 16225204)